Genome-wide association study of alcohol consumption and use disorder in 274,424 individuals from multiple populations HR Kranzler, H Zhou, RL Kember, R Vickers Smith, AC Justice, ... Nature communications 10 (1), 1499, 2019 | 450 | 2019 |
Gabapentin misuse, abuse and diversion: a systematic review RV Smith, JR Havens, SL Walsh Addiction 111 (7), 1160-1174, 2016 | 361 | 2016 |
Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits H Zhou, JM Sealock, S Sanchez-Roige, TK Clarke, DF Levey, Z Cheng, ... Nature neuroscience 23 (7), 809-818, 2020 | 277 | 2020 |
Meta-analysis of the antidepressant effects of acute sleep deprivation EM Boland, H Rao, DF Dinges, RV Smith, N Goel, JA Detre, M Basner, ... The Journal of Clinical Psychiatry 78 (8), 893, 2017 | 126 | 2017 |
Abuse and diversion of gabapentin among nonmedical prescription opioid users in Appalachian Kentucky RV Smith, MR Lofwall, JR Havens American Journal of Psychiatry 172 (5), 487-488, 2015 | 88 | 2015 |
Genome-wide association study of smoking trajectory and meta-analysis of smoking status in 842,000 individuals K Xu, B Li, KA McGinnis, R Vickers-Smith, C Dao, N Sun, RL Kember, ... Nature communications 11 (1), 5302, 2020 | 84 | 2020 |
Gabapentin drug misuse signals: A pharmacovigilance assessment using the FDA adverse event reporting system R Vickers-Smith, J Sun, RJ Charnigo, MR Lofwall, SL Walsh, JR Havens Drug and alcohol dependence 206, 107709, 2020 | 46 | 2020 |
Enhancing condom use among black male youths: A randomized controlled trial RA Crosby, RJ Charnigo, LF Salazar, R Pasternak, IW Terrell, JN Ricks, ... American journal of public health 104 (11), 2219-2225, 2014 | 46 | 2014 |
Cross-ancestry meta-analysis of opioid use disorder uncovers novel loci with predominant effects in brain regions associated with addiction RL Kember, R Vickers-Smith, H Xu, S Toikumo, M Niarchou, H Zhou, ... Nature Neuroscience 25 (10), 1279-1287, 2022 | 38 | 2022 |
Precision medicine and pharmacogenetics: what does oncology have that addiction medicine does not? HR Kranzler, RV Smith, R Schnoll, A Moustafa, E Greenstreet‐Akman Addiction 112 (12), 2086-2094, 2017 | 37 | 2017 |
A qualitative analysis of gabapentin misuse and diversion among people who use drugs in Appalachian Kentucky. R Vickers Smith, EM Boland, AM Young, MR Lofwall, A Quiroz, M Staton, ... Psychology of Addictive Behaviors 32 (1), 115, 2018 | 36 | 2018 |
Concurrent alcohol and medication poisoning hospital admissions among older rural and urban residents F Zanjani, R Smith, S Slavova, R Charnigo, N Schoenberg, C Martin, ... The American journal of drug and alcohol abuse 42 (4), 422-430, 2016 | 30 | 2016 |
Genome-wide association study of alcohol consumption and use disorder in 274,424 individuals from multiple populations. Nat Commun. 2019; 10 (1): 1499 HR Kranzler, H Zhou, RL Kember, R Vickers Smith, AC Justice, ... Largest GWAS of AUD to date, contrasted patterns of genetic relationships …, 2019 | 27 | 2019 |
The impact of service-connected disability and therapist experience on outcomes from prolonged exposure therapy with veterans. JT Goodson, AW Helstrom, EJ Marino, RV Smith Psychological trauma: theory, research, practice, and policy 9 (6), 647, 2017 | 27 | 2017 |
AUDIT‐C and ICD codes as phenotypes for harmful alcohol use: association with ADH1B polymorphisms in two US populations AC Justice, RV Smith, JP Tate, K McGinnis, K Xu, WC Becker, KY Lee, ... Addiction 113 (12), 2214-2224, 2018 | 24 | 2018 |
Perceived control and quality of life among recipients of implantable cardioverter defibrillator M Hammash, SM McEvedy, J Wright, J Cameron, J Miller, CF Ski, ... Australian Critical Care 32 (5), 383-390, 2019 | 23 | 2019 |
Individual and network correlates of antisocial personality disorder among rural nonmedical prescription opioid users RV Smith, AM Young, UL Mullins, JR Havens The Journal of Rural Health 33 (2), 198-207, 2017 | 23 | 2017 |
Activating veterans toward sources of reward: A pilot report on development, feasibility, and clinical outcomes of a 12-week behavioral activation group treatment R Hershenberg, RV Smith, JT Goodson, ME Thase Cognitive and Behavioral Practice 25 (1), 57-69, 2018 | 20 | 2018 |
Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran program M Serper, M Vujkovic, DE Kaplan, RM Carr, KM Lee, Q Shao, DR Miller, ... PloS one 15 (8), e0237430, 2020 | 18 | 2020 |
Genetic underpinnings of the transition from alcohol consumption to alcohol use disorder: shared and unique genetic architectures in a cross-ancestry sample RL Kember, R Vickers-Smith, H Zhou, H Xu, M Jennings, C Dao, L Davis, ... American journal of psychiatry 180 (8), 584-593, 2023 | 17 | 2023 |